Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2021-07-16 Earnings Release
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Korekta Raportu ESPI 34/2021 "Szacunkowe wyniki drugiego kwartału 2021 r." - Content (PL)
Earnings Release Classification · 100% confidence The document text is a notification from the management board of Mercator Medical S.A. regarding the estimated financial results for the second quarter of 2021 (Q2 2021). It provides key preliminary figures such as consolidated sales revenue, EBITDA, and net profit, comparing them to previous periods. This content—the initial announcement of key periodical financial results—fits the definition of an Earnings Release (ER). Although it mentions that the full report for the first half of 2021 is being prepared, the core content provided here is the preliminary earnings summary for Q2 2021. Q2 2021
2021-07-16 Polish
Szacunkowe wyniki drugiego kwartału 2021 r. - Content (PL)
Earnings Release Classification · 99% confidence The document text is very short (276 characters) and appears to be an initial announcement in Polish regarding estimated financial results for the second quarter of 2021 ("w drugim kwartale 2021 roku"). This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, typically providing key highlights before the full report is issued. It is not a full report (10-K or IR) nor a transcript (CT). Given the nature of preliminary results announcement, ER is the most appropriate classification. Q2 2021
2021-07-16 Polish
Zmiana znaczącej umowy - Content (PL)
Regulatory Filings Classification · 90% confidence The document is a short announcement (1257 characters) from the Management Board ('Zarząd spółki') of Mercator Medical S.A. It references a previous current report ('raport bieżący') regarding a supply agreement for nitrile gloves. The text details the value of deliveries already made, deliveries currently in progress, a reduction in the total contract value, and the schedule for remaining deliveries. This content relates to significant business transactions and contract fulfillment updates. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific, material update concerning business operations and contract value changes, it fits best under the general category for regulatory announcements that are not covered by more specific codes like DIRS, DIV, or CAP. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, material, non-standard business update, although it could potentially be argued as a type of 'Capital/Financing Update' (CAP) if the contract value change was deemed a major financing event, but it seems more like a standard operational update. Revisiting the definitions, none perfectly capture a 'Material Contract Update'. - ER/IR: Not financial results. - MDA: Not a detailed management explanation of results/outlook. - CAP: Not fundraising/financing structure change. - LTR: Not legal proceedings. Since this is a 'raport bieżący' (current report) detailing the status of a major supply contract, and it doesn't fit the highly specific categories, the general regulatory filing category 'RNS' (Regulatory Filings) is the most suitable classification.
2021-07-16 Polish
Zmiana znaczącej umowy - Content (PL)
Regulatory Filings Classification · 99% confidence The document is a short announcement (1368 characters) from a Polish entity ("Zarząd spółki Mercator Medical S.A.") regarding updates on existing supply contracts with a third party (Cardinal Health). It details realized delivery values, canceled contract values, and remaining contract values. This type of specific, material operational update that doesn't fit neatly into standard financial reports (10-K, IR, ER) or governance filings (DEF 14A, DVA) is best classified as a general Regulatory Filing (RNS) in the context of the provided definitions, especially given its nature as a 'raport bieżący' (current report) updating prior disclosures. It is not a presentation (IP), a transcript (CT), or a formal financial statement (IR, 10-K). Since it is a specific operational update, RNS is the most appropriate fallback.
2021-07-16 Polish
Asymilacja akcji Emitenta - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document text is very short (349 characters) and announces a specific corporate action by the Management Board ('Zarząd spółki Mercator Medical S.A.'). The action involves the assimilation (merger/consolidation) of 42,641 shares by the National Securities Depository (KDPW) into the existing listed shares. This action directly relates to a change in the company's capital structure or share registration status. Among the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate fit for an announcement concerning the assimilation/consolidation of shares, as it directly impacts the structure of the outstanding equity.
2021-07-12 Polish
Dopuszczenie i wprowadzenie do obrotu giełdowego akcji Emitenta - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document text is a formal announcement from the Management Board ('Zarząd') of Mercator Medical S.A. regarding a decision by the Warsaw Stock Exchange ('GPW') to admit 42,641 series H shares to trading on the main market, effective July 14, 2021. This concerns the listing and trading of new shares, which falls under capital structure changes or share issuance/listing events. Since the document explicitly details the admission of new shares to the stock exchange, it aligns best with the 'Share Issue/Capital Change' category (SHA). It is not a general regulatory filing (RNS) because it is specific to a capital event, nor is it a financing update (CAP) which usually implies fundraising or debt issuance.
2021-07-08 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.